Literature DB >> 25824440

Positive Family History, Infection, Low Absolute Lymphocyte Count (ALC), and Absent Thymic Shadow: Diagnostic Clues for All Molecular Forms of Severe Combined Immunodeficiency (SCID).

Laurie M McWilliams1, Mary Dell Railey1, Rebecca H Buckley2.   

Abstract

BACKGROUND: Severe combined immunodeficiency (SCID) is a syndrome uniformly fatal during infancy unless recognized and treated successfully by bone marrow transplantation or gene therapy. Because infants with SCID have no abnormal physical appearance, diagnosis is usually delayed unless newborn screening is performed.
OBJECTIVE: In this study, we sought to evaluate the presenting features of all 172 patients with SCID transplanted at this institution over the past 31 years.
METHODS: We reviewed original charts from 172 consecutive patients with classic SCID who received either T-cell-depleted HLA-haploidentical (N = 154) or HLA-identical (N = 18) nonablative related marrow transplants at Duke University Medical Center from 1982 to 2013.
RESULTS: The mean age at presentation was 4.87 months. When there was a family history of early infant death or known SCID (37%), the mean presentation age was much earlier, 2.0 months compared with 6.6 months. Failure to thrive was common, with 84 patients (50%) having a weight less than the 5th percentile. The leading infections included oral moniliasis (43%), viral infections (35.5%), and Pneumocystis jiroveci (26%) pneumonia. The group mean absolute lymphocyte count (ALC) was 1454/cmm; 88% of the infants had an ALC less than 3000/cmm. An absent thymic shadow was seen in 92% of infants with electronic radiographic data available. An absence of T-cell function was found in all patients.
CONCLUSIONS: Infants with SCID appear normal at birth but later present with failure to thrive and/or recurrent fungal, viral, and bacterial infections. Low ALCs and an absent thymic shadow on chest x-ray are key diagnostic clues. The absence of T-cell function confirms the diagnosis.
Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Absent thymic shadow; Failure to thrive infections; Lymphopenia; Severe combined immunodeficiency

Mesh:

Substances:

Year:  2015        PMID: 25824440      PMCID: PMC4500664          DOI: 10.1016/j.jaip.2015.01.026

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  29 in total

1.  Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants.

Authors:  R H Buckley; R I Schiff; S E Schiff; M L Markert; L W Williams; T O Harville; J L Roberts; J M Puck
Journal:  J Pediatr       Date:  1997-03       Impact factor: 4.406

2.  Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

Authors:  R H Buckley; S E Schiff; R I Schiff; L Markert; L W Williams; J L Roberts; L A Myers; F E Ward
Journal:  N Engl J Med       Date:  1999-02-18       Impact factor: 91.245

3.  RAG mutations in human B cell-negative SCID.

Authors:  K Schwarz; G H Gauss; L Ludwig; U Pannicke; Z Li; D Lindner; W Friedrich; R A Seger; T E Hansen-Hagge; S Desiderio; M R Lieber; C R Bartram
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

4.  Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.

Authors:  A Puel; S F Ziegler; R H Buckley; W J Leonard
Journal:  Nat Genet       Date:  1998-12       Impact factor: 38.330

5.  Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.

Authors:  M Noguchi; H Yi; H M Rosenblatt; A H Filipovich; S Adelstein; W S Modi; O W McBride; W J Leonard
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

6.  Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients.

Authors:  J L Stephan; V Vlekova; F Le Deist; S Blanche; J Donadieu; G De Saint-Basile; A Durandy; C Griscelli; A Fischer
Journal:  J Pediatr       Date:  1993-10       Impact factor: 4.406

7.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor.

Authors:  S M Russell; A D Keegan; N Harada; Y Nakamura; M Noguchi; P Leland; M C Friedmann; A Miyajima; R K Puri; W E Paul
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

8.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor.

Authors:  M Noguchi; Y Nakamura; S M Russell; S F Ziegler; M Tsang; X Cao; W J Leonard
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

9.  Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.

Authors:  Joseph L Roberts; Andrea Lengi; Stephanie M Brown; Min Chen; Yong-Jie Zhou; John J O'Shea; Rebecca H Buckley
Journal:  Blood       Date:  2003-11-13       Impact factor: 22.113

Review 10.  Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution.

Authors:  Rebecca H Buckley
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  5 in total

1.  Inborn Errors of Immunity in Patients with Adverse Events Following BCG Vaccination in Brazil.

Authors:  Paula T Lyra; Edvaldo Souza; Ana Carla A Moura; Marina C Matta; Leuridan C Torres; Antonio Victor Campos Coelho; Maria Ângela W Rocha; Luiz Arraes; João Bosco Oliveira
Journal:  J Clin Immunol       Date:  2022-07-30       Impact factor: 8.542

2.  SCID and Other Inborn Errors of Immunity with Low TRECs - the Brazilian Experience.

Authors:  Lucila Akune Barreiros; Jusley Lira Sousa; Christoph Geier; Alexander Leiss-Piller; Marilia Pylles Patto Kanegae; Tábata Takahashi França; Bertrand Boisson; Alessandra Miramontes Lima; Beatriz Tavares Costa-Carvalho; Carolina Sanchez Aranda; Maria Isabel de Moraes-Pinto; Gesmar Rodrigues Silva Segundo; Janaira Fernandes Severo Ferreira; Fabíola Scancetti Tavares; Flávia Alice Timburiba de Medeiros Guimarães; Eliana Cristina Toledo; Ana Carolina da Matta Ain; Iramirton Figueirêdo Moreira; Gustavo Soldatelli; Anete Sevciovic Grumach; Mayra de Barros Dorna; Cristina Worm Weber; Regina Sumiko Watanabe Di Gesu; Vera Maria Dantas; Fátima Rodrigues Fernandes; Troy Robert Torgerson; Hans Dietrich Ochs; Jacinta Bustamante; Jolan Eszter Walter; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2022-05-03       Impact factor: 8.542

3.  Combined immunodeficiency in the United States and Kuwait: Comparison of patients' characteristics and molecular diagnosis.

Authors:  Waleed Al-Herz; Luigi D Notarangelo; Ali Sadek; Rebecca Buckley
Journal:  Clin Immunol       Date:  2015-08-03       Impact factor: 3.969

4.  Family History of Early Infant Death Correlates with Earlier Age at Diagnosis But Not Shorter Time to Diagnosis for Severe Combined Immunodeficiency.

Authors:  Anderson Dik Wai Luk; Pamela P Lee; Huawei Mao; Koon-Wing Chan; Xiang Yuan Chen; Tong-Xin Chen; Jian Xin He; Nadia Kechout; Deepti Suri; Yin Bo Tao; Yong Bin Xu; Li Ping Jiang; Woei Kang Liew; Orathai Jirapongsananuruk; Tassalapa Daengsuwan; Anju Gupta; Surjit Singh; Amit Rawat; Amir Hamzah Abdul Latiff; Anselm Chi Wai Lee; Lynette P Shek; Thi Van Anh Nguyen; Tek Jee Chin; Yin Hsiu Chien; Zarina Abdul Latiff; Thi Minh Huong Le; Nguyen Ngoc Quynh Le; Bee Wah Lee; Qiang Li; Dinesh Raj; Mohamed-Ridha Barbouche; Meow-Keong Thong; Maria Carmen D Ang; Xiao Chuan Wang; Chen Guang Xu; Hai Guo Yu; Hsin-Hui Yu; Tsz Leung Lee; Felix Yat Sun Yau; Wilfred Hing-Sang Wong; Wenwei Tu; Wangling Yang; Patrick Chun Yin Chong; Marco Hok Kung Ho; Yu Lung Lau
Journal:  Front Immunol       Date:  2017-07-12       Impact factor: 7.561

Review 5.  Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations.

Authors:  Hans-Hartmut Peter; Hans D Ochs; Charlotte Cunningham-Rundles; Donald C Vinh; Peter Kiessling; Bernhard Greve; Stephen Jolles
Journal:  J Allergy Clin Immunol       Date:  2020-09       Impact factor: 10.793

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.